Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma

Human Pathology

Volumn 43, Issue 10, 2012, Pages 1559-1566

  Jung, Eun Jung ^a,b   Jung, Eun Ji ^a   Min, Sun Young ^a   Kim, Min A ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b National Medical Center   (South Korea)

Author keywords

Fibroblast growth factor receptor type II; Fluorescence in situ hybridization; Gene amplification; Stomach neoplasm; Survival analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

ADENOCARCINOMA; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866516574     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.12.002     Document Type: Article

References (33)

1. A. Jemal, M.M. Center, C. DeSantis, and E.M. Ward Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol Biomarkers Prev 19 2010 1893 1907
2. D.H. Roukos Targeting gastric cancer with Transtuzumab: new clinical practice and innovative developments to overcome resistance Ann Surg Oncol 17 2010 14 17
3. T. Ishikawa, M. Kobayashi, M. Mai, T. Suzuki, and A. Ooi Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization Am J Pathol 151 1997 761 768 (Pubitemid 27385608)
4. H.S. Kim, B.L. Lee, D.K. Woo, S.I. Bae, and W.H. Kim Assessment of markers for the identification of microsatellite instability phenotype in gastric neoplasms Cancer Lett 164 2001 61 68 (Pubitemid 32144990)
5. G.H. Kang, S. Lee, J.S. Kim, and H.Y. Jung Profile of aberrant CpG island methylation along multistep gastric carcinogenesis Lab Invest 83 2003 519 526 (Pubitemid 36457706)
6. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365 (Pubitemid 32467045)
7. G. Demetri, M. von Mehren, and C. Blanke Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 2002 472 480 (Pubitemid 34879334)
8. J. Paez, P. Janne, and J. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500 (Pubitemid 38720929)
9. C. Sawyers, A. Hochhaus, and E. Feldman Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 99 2002 3530 3539 (Pubitemid 34534519)
10. R. Grose, and C. Dickson Fibroblast growth factor signaling in tumorigenesis Cytokine Growth Factor Rev 16 2005 179 186 (Pubitemid 40616115)
11. M. Katoh FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26 Int J Oncol 22 2003 1155 1159
12. V. Eswarakumar, I. Lax, and J. Schlessinger Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev 16 2005 139 149 (Pubitemid 40616112)
13. W. Reardon, R. Winter, P. Rutland, L. Pulleyn, B. Jones, and S. Malcolm Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome Nat Genet 8 1994 98 103 (Pubitemid 24274068)
14. M. Passos-Bueno, W. Wilcox, E. Jabs, A. Sertie, L. Alonso, and H. Kitoh Clinical spectrum of fibroblast growth factor receptor mutations Hum Mutat 14 1999 115 125 (Pubitemid 29372778)
15. J.H. Jang, K.H. Shin, and J.G. Park Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers Cancer Res 61 2001 3541 3543
16. H. Davies, C. Hunter, and R. Smith Somatic mutations of the protein kinase gene family in human lung cancer Cancer Res 65 2005 7591 7595 (Pubitemid 41297230)
17. S. Byron, M. Gartside, and C. Wellens FGFR2 mutations are rare across histologic subtypes of ovarian cancer Gynecol Oncol 117 2010 125 129
18. P. Pollock, M. Gartside, and L. Dejeza Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes Oncogene 26 2007 7158 7162 (Pubitemid 350059681)
19. M. Heiskanen, J. Kononen, and M. Barlund CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors Anal Cell Pathol 22 2001 229 234 (Pubitemid 32960014)
20. Y. Hattori, H. Odagiri, and H. Nakatani K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes Proc Natl Acad Sci USA 87 1990 5983 5987
21. D. Easton, K. Pooley, and A. Dunning Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 2007 1087 1093 (Pubitemid 47014426)
22. A. Beenken, and M. Mohammadi The FGF family: biology, pathophysiology and therapy Nat Rev Drug Discov 8 2009 235 253
23. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors 7th ed. 2009 Wiley-Blackwell Oxford
24. M.A. Kim, H.J. Lee, H.K. Yang, Y.J. Bang, and W.H. Kim Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma Histopathology 59 2011 822 831
25. A. Dutt, H.B. Salvesen, and T.H. Chen Drug-sensitive FGFR2 mutations in endometrial carcinoma Proc Natl Acas Sci USA 105 2008 8713 8717 (Pubitemid 351987745)
26. M. Takeda, T. Arao, and H. Yokote AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor Clin Cancer Res 13 2007 3051 3057 (Pubitemid 46849582)
27. K. Nakamura, M. Yashiro, and T. Matsuoka A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for scirrhous gastric cancer Gastroenterology 131 2006 1530 1541 (Pubitemid 44708935)
28. Y. Hattori, H. Itoh, and S. Uchino Immunohistochemical detection of K-sam protein in stomach cancer Clin Cancer Res 2 1996 1373 1381 (Pubitemid 26299437)
29. T. Hara, A. Ooi, M. Kobayashi, M. Mai, K. Yanagihara, and I. Nakanishi Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization Lab Invest 78 1998 1143 1153 (Pubitemid 28440830)
30. H. Nakatani, H. Sakamoto, and T. Yoshida Isolation of an amplified DNA sequence in stomach cancer Jpn J Cancer Res 81 1990 707 710 (Pubitemid 20246912)
31. T. Ueki, T. Koji, S. Tamiya, P.K. Nakane, and M. Tsuneyoshi Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma J Pathol 177 1995 353 361
32. T. Toyokawa, M. Yashiro, and K. Hirakawa Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma Oncol Rep 21 2009 875 880
33. I.B. Weinstein, and A. Joe Oncogene addiction Cancer Res 68 2008 3077 3080